期刊文献+

帕金森病运动并发症影响因素的研究进展

Research Progress of the Factors for Motor Complications of Parkinson’s Disease
下载PDF
导出
摘要 帕金森病是一种常见于中老年人的运动障碍疾病,目前治疗以多巴胺替代疗法为主,但长期服用左旋多巴可产生运动并发症。近年来,国内外学者对左旋多巴治疗帕金森病诱发运动并发症的影响因素进行了广泛的研究,认为其受疾病严重程度、病程、左旋多巴剂量及治疗时程等多种因素的影响,而发病年龄为保护性因素,不同药物的使用可延缓运动并发症的出现。 Parkinson’s disease is a common movement disorders in the middle and old aged people.At present,the most important treatment method is dopamine replacement therapy,but the long-term use of levodopa is associated with the development of motor complications.In recent years,scholars at home and abroad have done a lot of researches in factors affecting levodopa-induced motor complications in Parkinson’s disease.It is considered to be affected by many factors,such as the severity and course of diseases,levodopa dose and treatment schedules.However,the age of onset is a protective factor,and different drugs can delay the appearance of motor complications.
出处 《医学综述》 2010年第9期1371-1373,共3页 Medical Recapitulate
关键词 帕金森病 运动并发症 影响因素 Parkinson’s disease Motor complications Factors
  • 相关文献

参考文献19

  • 1Hauser RA,McDermott MP,Messing S.Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease[J].Arch Neurol,2006,63(12):1756-1760. 被引量:1
  • 2Aubert I,Guigoni C,Hakansson K,et al.Increased D1 dopamine receptor signaling in levodopa induced dyskinesia[J].Ann Neurol,2005,57(1):17-26. 被引量:1
  • 3Encamacion EV,Hauser RA.Levodopa-induced dyskinesias in Parkinson's disease:etiology,impact on quality of life,and treatments[J].Eur Neurol,2008,60(1):57-66. 被引量:1
  • 4de la Fuente-Fernandez R,Sossi V,Huang Z,et al.Levodopa-in-duced changes in synaptic dopamine levels increase with progression of Parkinson's disease:implications for dyskinesias[J].Brain,2004,127 (12):2747-2754. 被引量:1
  • 5Sossi V.,De La Fuente-Fernández R.,Schulzer M.,张慧.帕金森病患者左旋多巴动力学的年龄相关性差异:与运动并发症的联系[J].世界核心医学期刊文摘(神经病学分册),2006,2(9):41-42. 被引量:1
  • 6Schoenfeld MA,Pantelie CM,Schwartz B.Clinical criteria for the switch of treatment strategies in Parkinson's disease[J].Clin Neurol Neurosurg,2003,5(4):241-244. 被引量:1
  • 7Vaamonde J,Ibanez R,Gudin M,et al.Fluctuations and dyskinesias as early L-dopa-induced motor complications in severe Parkinsonian's patients[J].Neurologia,2003,18(2):162-165. 被引量:1
  • 8Thanvi BR,Lo TC.Long term motor complications of levodopa:clinical features,mechanisms and management strategies[J].Postgrad Med J,2004,80(5):452-458. 被引量:1
  • 9Del Sorbo F,Albanese A.Levodopa-induced dyskinesias and their management[J].J Neurol,2008,255(4):32-41. 被引量:1
  • 10Pearce RK,Heikkila M,Linden IB,et al.L-dopa induces dyskinesia in normal monkeys:behavioural and pharmacokinetic observations[J].Psychopharmacology (Berl),2001,156(4):402-409. 被引量:1

二级参考文献1

  • 1Regina Katzenschlager,Andrew J. Lees. Treatment of Parkinson’s disease: levodopa as the first choice[J] 2002,Journal of Neurology(2):ii19~ii24 被引量:1

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部